Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Otolaryngology · Ménière Disease

Can MRI Show Hydrops in Both Ears With One-Sided Symptoms?

At a Glance

An MRI can show fluid buildup, called endolymphatic hydrops, in both ears even when Ménière’s symptoms occur in only one. This finding alone does not diagnose bilateral disease or predict future symptoms; doctors combine imaging with hearing, balance, and symptom changes.

Yes. It is entirely possible for a specialized inner-ear MRI to show endolymphatic hydrops (fluid buildup) in both ears, even if you only experience Ménière’s symptoms in one. Seeing this on your radiology report can be alarming, but having radiologic hydrops in your “good” ear does not automatically mean you have or will inevitably develop bilateral Ménière’s disease [1] [2].

The Bottom Line: Bilateral hydrops on an MRI is an imaging observation. It does not mean you currently have bilateral Ménière’s disease, it cannot guarantee that you will develop it, and the MRI finding alone does not decide whether treatments like gentamicin are appropriate [1] [3].

Understanding the Mismatch Between MRI and Symptoms

Endolymphatic hydrops is a physical finding—a swelling of the fluid compartments in the inner ear. However, Ménière’s disease is a clinical diagnosis. It is not diagnosed simply by looking at an MRI, but rather by observing a specific pattern of clinical criteria: recurrent spontaneous vertigo episodes, hearing loss that is documented on an audiogram, and fluctuating aural fullness or tinnitus [2] [4].

Research shows that the physical presence of fluid buildup on an MRI does not always correlate with experiencing active symptoms:

  • Silent hydrops in unilateral disease: In patients diagnosed with Ménière’s disease in only one ear, MRI detects asymptomatic hydrops in the opposite “good” ear in roughly 8% to 24% of cases [5] [6] [7]. These percentages vary heavily depending on the specific delayed-contrast MRI technique used and the exact population studied.
  • Hydrops in healthy ears: Radiologic hydrops is not completely specific to Ménière’s disease. It has been found in up to 31% of healthy volunteers evaluated in studies, meaning it can sometimes be an incidental finding that causes no problems [1].

Why does the fluid cause debilitating symptoms in one ear but remain totally silent in the other? The exact reason is still being researched. Experts believe that clinical symptoms depend on more than just the presence of fluid; they may relate to microscopic differences in how well the inner ear structures—like the endolymphatic sac—drain and manage that fluid [8] [9].

Concept What It Is What It Means
MRI Hydrops A radiologic observation of fluid swelling. Does not confirm a diagnosis. Must be interpreted alongside symptoms.
Ménière’s Disease A clinical syndrome. Diagnosed through recurrent vertigo, audiogram hearing loss, and ear symptoms.

Will the “Good” Ear Eventually Develop Symptoms?

The presence of silent hydrops in your unaffected ear indicates a structural change, and some studies suggest it may be associated with a higher likelihood of eventually developing bilateral disease [10]. However, an MRI simply cannot predict whether or when your asymptomatic ear will ever develop symptoms [6]. Small long-term studies have seen some asymptomatic ears transition into typical Ménière’s disease over several years, but this does not happen to everyone, and many patients remain stable [10] [11].

Rather than assuming the worst, doctors recommend practical monitoring of the “good” ear. You and your care team should establish your baseline hearing and vestibular function, and watch for subtle changes like:

  • New or fluctuating tinnitus (ringing)
  • A feeling of pressure or fullness
  • Mild drops in hearing clarity or volume

Note on Urgent Care: If you experience a sudden, rapid drop in your hearing—especially in your only “good” ear—do not wait for a routine checkup. Sudden hearing loss requires urgent, same-day medical assessment.

How Bilateral Findings Influence Treatment Decisions

When discussing treatments for severe vertigo—particularly ablative treatments like intratympanic gentamicin—knowing you have bilateral hydrops is one piece of the puzzle, but it is not the only factor [12].

Intratympanic gentamicin is an antibiotic injected through the eardrum to purposely reduce or ablate the inner ear’s balance function, which helps stop severe vertigo attacks [13]. It is typically given in carefully titrated doses to control vertigo while minimizing risks, but it does carry a risk of permanently damaging your hearing and balance in the treated ear [14] [15].

If your MRI shows hydrops in your asymptomatic ear, your doctor will discuss how this impacts your vestibular reserve (the total amount of balance function you have left). If you significantly reduce the balance function in your currently “bad” ear with gentamicin, your body will rely much more heavily on your “good” ear, visual cues, and physical sensation to keep you steady. If that “good” ear were to later develop Ménière’s disease and lose its own balance function, you could be left with bilateral vestibular hypofunction. This can cause significant physical disability, including unsteadiness in the dark and oscillopsia—a condition where your vision bounces or jiggles when you move your head because your brain cannot stabilize your eyes [16].

However, bilateral radiologic hydrops alone does not rule out using gentamicin [3]. Your doctor will weigh the MRI findings alongside how debilitating your current vertigo attacks are, your actual baseline hearing and vestibular test results, and how you have responded to other treatments. Non-destructive options like dietary changes, diuretics, or intratympanic steroid injections are often prioritized first to try to preserve function in both ears, though they are not guaranteed to stop vertigo and have their own varying success rates [12] [17].

Common questions in this guide

Does hydrops in both ears mean I have Ménière’s disease in both ears?
No. MRI-detected hydrops is a physical finding and does not by itself establish bilateral Ménière’s disease; doctors also consider vertigo episodes, hearing-test results, tinnitus, and ear pressure or fullness. Some people have hydrops without symptoms.
How often is hydrops found in the ear without symptoms?
In studies of people with Ménière’s disease in one ear, MRI has found silent hydrops in the other ear in about 8% to 24% of cases. Results vary with the delayed-contrast MRI method and study population, and hydrops has also been reported in some healthy volunteers.
Can an MRI tell me whether my other ear will become symptomatic?
No. Bilateral hydrops may be associated with a greater chance of later symptoms, but MRI cannot tell whether or when they will develop. Some asymptomatic ears become symptomatic over years, while many remain stable.
Could bilateral hydrops affect the decision to use gentamicin?
It can be one factor, but it does not automatically rule out intratympanic gentamicin. The clinician also weighs the severity of vertigo, hearing and balance test results, prior treatments, and the risk of reducing balance function or hearing in the treated ear.
What changes in my better ear should prompt medical attention?
New or fluctuating ringing, ear pressure, or reduced hearing should be reported and discussed as part of monitoring. A sudden rapid drop in hearing, especially in the only better ear, requires same-day medical assessment rather than waiting for a routine visit.
What follow-up testing is useful after bilateral hydrops is seen?
Your care team may establish baseline hearing and balance measurements and repeat them according to your symptoms and treatment plan. Track which ear has ringing, pressure, hearing changes, or vertigo so new changes are easier to identify.

Get notified when new evidence is published on endolymphatic hydrops.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (17)
  1. 1

    The "hype" of hydrops in classifying vestibular disorders: a narrative review.

    van der Lubbe MFJA, Vaidyanathan A, Van Rompaey V, et al.

    Journal of neurology 2020; (267(Suppl 1)):197-211 doi:10.1007/s00415-020-10278-8.

    PMID: 33201310
  2. 2

    Magnetic resonance imaging and Ménière's disease-unavoidable alliance.

    Sousa R, Raposo F, Guerreiro C, et al.

    Neuroradiology 2021; (63(11)):1749-1763 doi:10.1007/s00234-021-02744-5.

    PMID: 34142211
  3. 3

    Systematic review of magnetic resonance imaging for diagnosis of Meniere disease.

    Lopez-Escamez JA, Attyé A

    Journal of vestibular research : equilibrium & orientation 2019; (29(2-3)):121-129 doi:10.3233/VES-180646.

    PMID: 31356219
  4. 4

    [Menière's Disease].

    Plontke SK, Gürkov R

    Laryngo- rhino- otologie 2015; (94(8)):530-54 doi:10.1055/s-0035-1555808.

    PMID: 26243634
  5. 5

    Clinical Features and Endolymphatic Hydrops in Patients With MRI Evidence of Hydrops.

    Shi S, Guo P, Li W, Wang W

    The Annals of otology, rhinology, and laryngology 2019; (128(4)):286-292 doi:10.1177/0003489418819551.

    PMID: 30556402
  6. 6

    Endolymphatic hydrops in contralateral ear of patients with unilateral Meniere's disease.

    Wang J, Huang Y, Zhao P, et al.

    Acta oto-laryngologica 2026; (146(4)):500-507 doi:10.1080/00016489.2026.2613137.

    PMID: 41636232
  7. 7

    Gadolinium-enhanced MRI reveals dynamic development of endolymphatic hydrops in Ménière's disease.

    Li X, Wu Q, Sha Y, et al.

    Brazilian journal of otorhinolaryngology 2020; (86(2)):165-173 doi:10.1016/j.bjorl.2018.10.014.

    PMID: 30600169
  8. 8

    Endolymphatic hydrops in patients with unilateral and bilateral Meniere's disease.

    Morimoto K, Yoshida T, Sugiura S, et al.

    Acta oto-laryngologica 2017; (137(1)):23-28 doi:10.1080/00016489.2016.1217042.

    PMID: 27564645
  9. 9

    A three-dimensional analysis of the endolymph drainage system in Ménière disease.

    Monsanto RD, Pauna HF, Kwon G, et al.

    The Laryngoscope 2017; (127(5)):E170-E175 doi:10.1002/lary.26155.

    PMID: 27440440
  10. 10

    Ongoing Discrepancy Between Unilateral Meniere's Disease and Bilateral Endolymphatic Hydrops on Hydrops MRI.

    Yang TH, Meng LC, Young YH

    Laryngoscope investigative otolaryngology 2025; (10(4)):e70216 doi:10.1002/lio2.70216.

    PMID: 40746633
  11. 11

    Prognosis of asymptomatic endolymphatic hydrops in healthy volunteers: A five-year cohort study.

    Kimura T, Kitahara T, Okayasu T, et al.

    Laryngoscope investigative otolaryngology 2024; (9(6)):e70026 doi:10.1002/lio2.70026.

    PMID: 39525523
  12. 12

    International consensus (ICON) on treatment of Ménière's disease.

    Nevoux J, Barbara M, Dornhoffer J, et al.

    European annals of otorhinolaryngology, head and neck diseases 2018; (135(1S)):S29-S32 doi:10.1016/j.anorl.2017.12.006.

    PMID: 29338942
  13. 13

    Does Endolymphatic Hydrops Influences Gentamicin Effects in Meniere Disease Patients Undergoing Intratympanic Treatment?

    Lorente-Piera J, Suárez-Vega V, Blanco M, et al.

    Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 2026; (47(2)):e376-e382 doi:10.1097/MAO.0000000000004695.

    PMID: 41182860
  14. 14

    Long-term efficacy of triple semicircular canal plugging in the treatment of patients with ipsilateral delayed endolymphatic hydrops.

    Zhang D, Lv Y, Li X, et al.

    Scientific reports 2021; (11(1)):3156 doi:10.1038/s41598-021-82683-6.

    PMID: 33542390
  15. 15

    Intratympanic Gentamicin for Intractable Ménière's Disease - A Review and Analysis of Audiovestibular Impact.

    Yetişer S

    International archives of otorhinolaryngology 2018; (22(2)):190-194 doi:10.1055/s-0037-1604064.

    PMID: 29619111
  16. 16

    Aminoglycoside Vestibulotoxicity.

    Rutka J

    Advances in oto-rhino-laryngology 2019; (82()):101-110 doi:10.1159/000490277.

    PMID: 30947191
  17. 17

    Meniere's disease.

    Nakashima T, Pyykkö I, Arroll MA, et al.

    Nature reviews. Disease primers 2016; (2()):16028 doi:10.1038/nrdp.2016.28.

    PMID: 27170253

This page is for informational purposes only and is not medical advice. It explains how bilateral MRI hydrops may affect monitoring and treatment discussions, but your treating clinician must interpret your results.